[1] Falkinham JO 3rd. Surrounded by mycobacteria:nontuberculous mycobacteria in the human environment. J Appl Microbiol, 2009; 107, 356-67. doi:  10.1111/jam.2009.107.issue-2
[2] Castillo-Rodal AI, Mazari-Hiriart M, Lloret-Sanchez LT, et al. Potentially pathogenic nontuberculous mycobacteria found in aquatic systems. Analysis from a reclaimed water and water distribution system in Mexico City. Eur J Clin Microbiol Infect Dis, 2012; 31, 683-94. doi:  10.1007/s10096-011-1359-y
[3] Somoskovi A, Salfinger M. Nontuberculous mycobacteria in respiratory infections:advances in diagnosis and identification. Clin Lab Med, 2014; 34, 271-95. doi:  10.1016/j.cll.2014.03.001
[4] Thomson RM. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis, 2010; 16, 1576-83. doi:  10.3201/eid1610.091201
[5] Cassidy PM, Hedberg K, Saulson A, et al. Nontuberculous mycobacterial disease prevalence and risk factors:a changing epidemiology. Clin Infect Dis, 2009; 49, e124-9. doi:  10.1086/599195
[6] Shojaei H Magee JG, Freeman R, et al. Mycobacterium elephantis sp. nov., a rapidly growing non-chromogenic Mycobacterium isolated from an elephant. Int J Syst Evol Micr, 2000; 50 Pt 5, 1817-20. https://www.researchgate.net/profile/Hasan_Shojaei2/publication/12288911_Mycobacterium_elephantis_sp_nov_a_rapidly_growing_non-chromogenic_Mycobacterium_isolated_from_an_elephant/links/0c960524099db00417000000.pdf?origin=publication_detail
[7] Christine Turenne, Pamela Chedore, Joyce Wolfe, et al. Phenotypic and molecular characterization of clinical isolates of Mycobacterium elephantis from human specimens. J Clin Microbiol, 2002; 40, 1230-6. doi:  10.1128/JCM.40.4.1230-1236.2002
[8] Tortoli E, Rindi L, Bartoloni A, et al. Mycobacterium elephantis:not an exceptional finding in clinical specimens. Eur J Clin Microbiol Infect Dis, 2003; 22, 427-30. doi:  10.1007/s10096-003-0950-2
[9] Springer B, Stockman LTeschner K, Roberts GD, et al. Two-laboratory collaborative study on identification of mycobacteria:molecular versus phenotypic methods. J Clin Microbiol, 1996; 34, 296-303. http://jcm.asm.org/content/34/2/296.abstract
[10] Potters D, Seghers M, Muyldermans G, et al. Recovery of Mycobacterium elephantis from sputum of a patient in Belgium. J Clin Microbiol, 2003; 41, 1344. doi:  10.1128/JCM.41.3.1344.2003
[11] Huard Richard C, W Ray Butler, Dick Van Soolingen, et al. PCR-based method to differentiate the subspecies of the Mycobacterium tuberculosis complex on the basis of genomic deletions. J Clin Microbiol, 2003; 41, 1637-50. doi:  10.1128/JCM.41.4.1637-1650.2003
[12] Adékambi Toïdi, Drancourt Michel. Dissection of phylogenetic relationships among 19 rapidly growing Mycobacterium species by 16S rRNA, hsp65, sodA, recA and rpoB gene sequencing. Int J Syst Evol Micr, 2004; 54, 2095-105. doi:  10.1099/ijs.0.63094-0
[13] Roth A, Reischl U, Streubel A, et al. Novel diagnostic algorithm for identification of mycobacteria using genus-specific amplification of the 16S-23S rRNA gene spacer and restriction endonucleases. J Clin Microbiol, 2000; 38, 1094-104. https://www.researchgate.net/publication/12616661_Novel_Diagnostic_Algorithm_for_Identification_of_Mycobacteria_Using_Genus-Specific_Amplification_of_the_16S-23S_rRNA_Gene_Spacer_and_Restriction_Endonucleases
[14] Turenne CY, Tschetter L, Wolfe J, et al. Necessity of quality-controlled 16S rRNA gene sequence databases:identifying nontuberculous Mycobacterium species. J Clin Microbiol, 2001; 39, 3637-48. doi:  10.1128/JCM.39.10.3638-3648.2001
[15] Institue Clinical Laboratory Standards. Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes. approved standard-Second Edition. Document M24-A2, 31, 2011. https://www.researchgate.net/publication/285850333_Susceptibility_testing_of_mycobacteria_nocardiae_and_other_aerobic_actinomycetes
[16] Franzblau SG, Witzig RS, McLaughlin JC, et al. Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol, 1998; 36, 362-6. https://www.researchgate.net/publication/13763626_Rapid_Low-Technology_MIC_Determination_with_Clinical_Mycobacterium_tuberculosis_Isolates_by_Using_the_Microplate_Alamar_Blue_Assay
[17] Li G, Lian LL, Wan L, et al. Antimicrobial Susceptibility of Standard Strains of Nontuberculous Mycobacteria by Microplate Alamar Blue Assay. Plos One, 2013; 8, e84065. doi:  10.1371/journal.pone.0084065
[18] Agnieszka Broda, Heather Jebbari, Kate Beaton, et al. Comparative Drug Resistance of Mycobacterium abscessus and M. chelonae Isolates from Patients with and without Cystic Fibrosis in the United Kingdom. J Clin Microbiol, 2012; 51, 217-23. https://www.researchgate.net/publication/233333794_Comparative_Drug_Resistance_of_Mycobacterium_abscessus_and_M_chelonae_Isolates_from_Patients_with_and_without_Cystic_Fibrosis_in_the_United_Kingdom
[19] Van Ingen Jakko, Tridia Van Der Laan, Dekhuijzen Richard, et al. In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands. Int J Antimicrob Ag, 2009; 35, 169-73. http://repository.ubn.ru.nl/handle/2066/88100
[20] Telenti A, Marchesi F, Balz M, et al. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J Clin Microbiol, 1993; 31, 175-8. https://www.researchgate.net/publication/14817112_Rapid_identification_of_mycobacteria_to_the_species_level_by_polymerase_chain_reaction_and_restriction_enzyme_analysis
[21] Bodle Ethan E, Cunningham Jennifer A, Phyllis Della Latta, et al. Epidemiology of Nontuberculous Mycobacteria in Patients without HIV Infection, New York City. Emerg Infect Dis, 2008; 14, 390-6. doi:  10.3201/eid1403.061143
[22] Sami Simons, Jakko Van Ingen, Po-Ren Hsueh, et al. Nontuberculous mycobacteria in respiratory tract infections, eastern Asia. Emerg Infect Dis, 2011; 17, 343-9. doi:  10.3201/eid170310060